Noevir Holdings Co., Ltd. (4928.T)
JPY 4895.0
(1.03%)
JPY 4895.0
(1.03%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 24.04 Billion JPY | -1.46% |
| 2022 | 24.39 Billion JPY | -13.53% |
| 2021 | 28.21 Billion JPY | 1.46% |
| 2020 | 27.8 Billion JPY | -8.47% |
| 2019 | 30.38 Billion JPY | -1.41% |
| 2018 | 30.82 Billion JPY | -9.89% |
| 2017 | 34.2 Billion JPY | 1.19% |
| 2016 | 33.8 Billion JPY | 3.21% |
| 2015 | 32.75 Billion JPY | 2.22% |
| 2014 | 32.03 Billion JPY | -4.63% |
| 2013 | 33.59 Billion JPY | -1.23% |
| 2012 | 34.01 Billion JPY | -5.08% |
| 2011 | 35.83 Billion JPY | -2.59% |
| 2010 | 36.78 Billion JPY | -1.66% |
| 2009 | 37.4 Billion JPY | -15.41% |
| 2008 | 44.21 Billion JPY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 24.44 Billion JPY | -7.09% |
| 2024 Q2 | 26.31 Billion JPY | 5.27% |
| 2024 Q1 | 24.99 Billion JPY | 3.96% |
| 2023 Q1 | 25.65 Billion JPY | 5.16% |
| 2023 Q4 | 24.04 Billion JPY | -2.51% |
| 2023 Q3 | 24.66 Billion JPY | -5.07% |
| 2023 FY | 24.04 Billion JPY | -1.46% |
| 2023 Q2 | 25.97 Billion JPY | 1.24% |
| 2022 Q4 | 24.39 Billion JPY | -3.0% |
| 2022 Q3 | 25.15 Billion JPY | -5.54% |
| 2022 FY | 24.39 Billion JPY | -13.53% |
| 2022 Q1 | 29.16 Billion JPY | 3.37% |
| 2022 Q2 | 26.62 Billion JPY | -8.71% |
| 2021 Q3 | 29.17 Billion JPY | -0.07% |
| 2021 Q1 | 29.72 Billion JPY | 6.89% |
| 2021 FY | 28.21 Billion JPY | 1.46% |
| 2021 Q2 | 29.19 Billion JPY | -1.78% |
| 2021 Q4 | 28.21 Billion JPY | -3.28% |
| 2020 Q2 | 29.67 Billion JPY | -4.83% |
| 2020 Q1 | 31.18 Billion JPY | 2.62% |
| 2020 Q4 | 27.8 Billion JPY | -2.88% |
| 2020 FY | 27.8 Billion JPY | -8.47% |
| 2020 Q3 | 28.63 Billion JPY | -3.51% |
| 2019 Q1 | 31.3 Billion JPY | 1.58% |
| 2019 Q2 | 30.85 Billion JPY | -1.44% |
| 2019 FY | 30.38 Billion JPY | -1.41% |
| 2019 Q4 | 30.38 Billion JPY | -2.15% |
| 2019 Q3 | 31.05 Billion JPY | 0.63% |
| 2018 Q4 | 30.82 Billion JPY | -3.14% |
| 2018 FY | 30.82 Billion JPY | -9.89% |
| 2018 Q2 | 31.96 Billion JPY | -4.62% |
| 2018 Q1 | 33.51 Billion JPY | -2.02% |
| 2018 Q3 | 31.81 Billion JPY | -0.46% |
| 2017 Q1 | 35.11 Billion JPY | 3.88% |
| 2017 FY | 34.2 Billion JPY | 1.19% |
| 2017 Q4 | 34.2 Billion JPY | -2.65% |
| 2017 Q3 | 35.13 Billion JPY | 0.23% |
| 2017 Q2 | 35.05 Billion JPY | -0.17% |
| 2016 Q4 | 33.8 Billion JPY | 0.0% |
| 2016 Q3 | 33.8 Billion JPY | -2.34% |
| 2016 FY | 33.8 Billion JPY | 3.21% |
| 2016 Q1 | 36.45 Billion JPY | 11.29% |
| 2016 Q2 | 34.61 Billion JPY | -5.05% |
| 2015 Q4 | 32.75 Billion JPY | -2.21% |
| 2015 Q3 | 33.49 Billion JPY | 1.26% |
| 2015 Q2 | 33.07 Billion JPY | 2.59% |
| 2015 Q1 | 32.24 Billion JPY | 0.63% |
| 2015 FY | 32.75 Billion JPY | 2.22% |
| 2014 Q3 | 32.33 Billion JPY | -1.66% |
| 2014 Q2 | 32.88 Billion JPY | 1.39% |
| 2014 Q1 | 32.43 Billion JPY | -3.45% |
| 2014 FY | 32.03 Billion JPY | -4.63% |
| 2014 Q4 | 32.03 Billion JPY | -0.93% |
| 2013 Q1 | 33.53 Billion JPY | -1.4% |
| 2013 Q4 | 33.59 Billion JPY | -2.26% |
| 2013 FY | 33.59 Billion JPY | -1.23% |
| 2013 Q3 | 34.37 Billion JPY | 6.2% |
| 2013 Q2 | 32.36 Billion JPY | -3.49% |
| 2012 Q2 | 33.39 Billion JPY | -2.26% |
| 2012 Q3 | 34.5 Billion JPY | 3.31% |
| 2012 Q4 | 34.01 Billion JPY | -1.43% |
| 2012 FY | 34.01 Billion JPY | -5.08% |
| 2012 Q1 | 34.17 Billion JPY | 0.0% |
| 2011 FY | 35.83 Billion JPY | -2.59% |
| 2011 Q3 | 36.01 Billion JPY | 0.0% |
| 2010 FY | 36.78 Billion JPY | -1.66% |
| 2009 FY | 37.4 Billion JPY | -15.41% |
| 2008 FY | 44.21 Billion JPY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Kitanotatsujin Corporation | 1.65 Billion JPY | -1354.641% |
| Euglena Co., Ltd. | 37.92 Billion JPY | 36.604% |
| BEAUTY GARAGE Inc. | 6.49 Billion JPY | -270.289% |
| Axas Holdings Co.,Ltd. | 14.58 Billion JPY | -64.883% |
| C.I. Medical Co.,Ltd. | 21.36 Billion JPY | -12.515% |
| Kao Corporation | 757.7 Billion JPY | 96.827% |
| Niitaka Co., Ltd. | 9.35 Billion JPY | -156.947% |
| Rohto Pharmaceutical Co.,Ltd. | 99.13 Billion JPY | 75.749% |
| Shiseido Company, Limited | 615.1 Billion JPY | 96.092% |
| Lion Corporation | 188.22 Billion JPY | 87.228% |
| Mandom Corporation | 20.05 Billion JPY | -19.869% |
| Ivy Cosmetics Corporation | 1.32 Billion JPY | -1711.956% |
| Milbon Co., Ltd. | 7.45 Billion JPY | -222.284% |
| Nippon Shikizai, Inc. | 13.56 Billion JPY | -77.292% |
| Fancl Corporation | 30.56 Billion JPY | 21.352% |
| KOSÉ Corporation | 88.61 Billion JPY | 72.871% |
| Cota Co., Ltd. | 3.85 Billion JPY | -524.014% |
| HABA Laboratories,Inc. | 3.92 Billion JPY | -512.651% |
| C'bon Cosmetics Co.,Ltd. | 3.14 Billion JPY | -663.486% |
| Pola Orbis Holdings Inc. | 33.26 Billion JPY | 27.72% |
| Adjuvant Holdings Co.,Ltd. | 1.06 Billion JPY | -2159.301% |
| Almado, Inc. | 1.94 Billion JPY | -1135.167% |
| I-ne CO., LTD. | 8.57 Billion JPY | -180.263% |
| Premier Anti-Aging Co., Ltd. | 4.88 Billion JPY | -392.643% |
| Liberta Co.,Ltd. | 3.88 Billion JPY | -519.043% |
| AXXZIA Inc. | 2 Billion JPY | -1098.184% |
| S.T. Corporation | 12.01 Billion JPY | -100.158% |
| Kobayashi Pharmaceutical Co., Ltd. | 62.65 Billion JPY | 61.63% |
| Earth Corporation | 60.4 Billion JPY | 60.2% |
| Sagami Rubber Industries Co., Ltd. | 7.79 Billion JPY | -208.289% |
| Asahi Eito Holdings Co.,Ltd. | 1.61 Billion JPY | -1390.41% |
| Ya-Man Ltd. | 3.97 Billion JPY | -504.589% |
| MTG Co., Ltd. | 11.73 Billion JPY | -104.796% |
| TRANSACTION CO.,Ltd. | 4.17 Billion JPY | -476.236% |
| SHOBIDO Corporation | 8.89 Billion JPY | -170.207% |
| Artnature Inc. | 23.42 Billion JPY | -2.621% |
| Pigeon Corporation | 19.34 Billion JPY | -24.249% |
| Unicharm Corporation | 345.37 Billion JPY | 93.039% |
| Paltac Corporation | 222.34 Billion JPY | 89.187% |
| CB GROUP MANAGEMENT Co., Ltd. | 28.51 Billion JPY | 15.687% |